Diversified Healthcare Trust (DHC) AI Stock Analysis

Diversified Healthcare Trust (DHC) operates as a specialized real estate investment trust (REIT), focusing on a diversified portfolio that includes medical office buildings, life science properties, senior living communities, and wellness centers across the United States. As part of The RMR Group Inc., an alternative asset management company headquartered in Newton, MA, DHC benefits from an operational framework and strategic oversight. The company acquires and manages properties catering to the healthcare and wellness sectors, seeking to optimize portfolio value and operational efficiency while capitalizing on demographic trends.

Revenue rose from $1.38B in FY2021 to $1.54B in FY2025, reflecting a 5-year CAGR of -1.2%. Profitability has remained strained, with net income falling from $174.5M in FY2021 to -$285.9M in FY2025, alongside a gross margin of -16.0% and an operating margin of -2.6%. For the trailing twelve months, revenue totaled $1.50B with an operating margin of -0.1% and a profit margin of -17.7%. In the latest quarter ended June 30, 2026, quarterly revenue growth declined 4.5% year-over-year, while quarterly earnings growth dropped 68.4%.

As of June 30, 2026, Diversified Healthcare Trust held $116.8M in cash and short-term investments alongside total debt of $2.42B, resulting in net debt of $2.30B. Shareholders' equity stood at $1.58B, resulting in a debt-to-equity ratio of 1.53, while the current ratio was 188.99. Operating cash flow and free cash flow were both -$19.6M in FY2025, after reaching $112.2M in FY2024. In FY2025, capital allocation included $1.1M spent on share buybacks and $9.7M distributed in dividends.

At a share price of $7.59, Diversified Healthcare Trust trades at a market capitalization of $1.84B and an enterprise value of $4.26B. Its forward P/E of 16.6x sits below the US-listed Real Estate median of 23.5x, and its price-to-sales ratio of 1.2x compares to the peer median of 3.7x. Conversely, its EV/EBITDA multiple of 34.0x is higher than the peer median of 14.7x. DHC generated a 1-year return of 86.3% and a 5-year return of 123.3%, outperforming the S&P 500 (SPY) returns of 16.8% and 83.0% over the same periods.

DHC pays a quarterly dividend with an annual forward payout of $0.04 per share, translating to a dividend yield of 0.53% and a payout ratio of 2.3%. The company has paid dividends for 28 consecutive years, though its 5-year annualized dividend growth stands at -26.0%. Its most recent ex-dividend date was October 19, 2026.

Wall Street coverage consists of 2 Strong Buy, 1 Buy, and 2 Hold ratings, with no Sell or Strong Sell recommendations. The mean price target is $10.15, implying an upside of 33.7% above the last close of $7.59. For the current fiscal year ending December 31, 2026, consensus estimates project an EPS of -$0.63 on revenue of $1.47B. DHC has exceeded EPS estimates in all 4 of the last 4 quarters, with its next earnings release scheduled for November 2, 2026.

This page is an AI-written research summary of Diversified Healthcare Trust (DHC). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: DHC income statement, DHC balance sheet, DHC key metrics, DHC analyst forecast, DHC chart. See the DHC stock overview for the latest quote and news.